Jiun-i J. Lai
Taipei, TNQ, Taiwan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 50 publications
2025 Update of the Taiwan Expert Consensus on Hormone Receptor-Positive Metastatic Breast Cancer Management.
Journal: Journal of breast cancer
Published: April 09, 2026
Pan-cancer analysis identifies immunoproteasome as the predominant survival-associated component of antigen processing machinery.
Journal: Translational oncology
Published: March 19, 2026
Management of hormone receptor-positive/human epidermal growth factor receptor 2-negative breast cancer patients: beyond endocrine therapy.
Journal: Journal of the Chinese Medical Association : JCMA
Published: December 29, 2025
Platinum and 5-FU Salvage Therapy for Severe Liver Crisis in Metastatic Breast Cancer: Efficacy and Analysis of Prognostic Factors.
Journal: Cancer research and treatment
Published: November 18, 2025
Gamma knife radiosurgery for breast cancer brain metastasis: survival outcomes, prognotic factors, and the role of repeat treatment.
Journal: Journal of neuro-oncology
Published: June 30, 2025
ITGB2 Gene Gain as a Prognostic Marker for Early Recurrence in Luminal HER2-Negative High Proliferative Breast Cancer.
Journal: Cancer research and treatment
Published: June 23, 2025
Real-world evaluation of CDK4/6 inhibitors in hormone receptor-positive metastatic breast cancer: prognostic effect of proton pump inhibitor use.
Journal: The oncologist
Published: April 29, 2025
Efficacy of adjuvant nivolumab in patients with upper tract predominant urothelial carcinoma: A single-center real-world study.
Journal: Urologic oncology
Published: April 29, 2025
Real-world experience in treatment outcome and genomic insights for metastatic prostate neuroendocrine carcinoma.
Journal: Journal of the Chinese Medical Association : JCMA
Published: April 18, 2025
Circulating T-cell receptor repertoire and clinicopathological correlations in breast cancer patients: immune repertoire analysis from the VGH-TAYLOR study.
Journal: Breast cancer research : BCR
Published: April 14, 2025
Abemaciclib Plus Fulvestrant in Advanced Breast Cancer After Progression on CDK4/6 Inhibition: Results From the Phase III postMONARCH Trial.
Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology
Published: December 18, 2024
Last Updated: 09/26/2026